Mller TD, Finan B, Bloom SR et al (2019) Glucagon-like peptide 1 (GLP-1)
Tirzepatide has demonstrated significant improvements in glycaemic control compared with placebo for managing glycated haemoglobin (HbA1c) levels, and its efficacy has been shown to depend on both GIP and GLP-1 receptor-mediated actions [13]
timing considerations apply for women depending on menstrual status), oestradiol, LH, FSH Thyroid function: TSH and free T4 if TSH is abnormal General health markers based on clinical indication: full blood count, ferritin, vitamin D (if at risk of deficiency), HbA1c (if cardiovascular or diabetes risk factors present) Depending on findings, referral to specialist services may be appropriate, including endocrinology for hormonal disorders, gynaecology for menstrual disturbances, or psychology services for eating disorders or relationship counselling
Explore other GLP-1 medications for weight loss Stop guessing